K. D. Wlsnlvesky, J. P. Wyer-p, P. D. Adler-r, T. Mc-glnn, . Gurbir et al., The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department : a systematic review. BMC Emergency Medicine Evaluation of B-type Natriuretic Peptide for validation of a heart failure register in primary care, BMC Cardiovascular Disorders, vol.7, p.23, 2006.

D. and H. M. De-gevigney-g.-l-'insuffisance-cardiaque-de-l-'adulte, Cours faculté de Médecine de Lyon Consulté octobre 2006 à : http://spiral.univlyonl .fr/pol~cops/Cardioloaie/Cardioloaie-7 Cardiopulmonary exercise testing for evaluation of chronic cardiac failure, American Journal of Cardiology, vol.1, issue.55, pp.985-1007, 2006.

C. and J. G. Cleland, The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure, European Heart Journal, vol.26, pp.1742-1743

F. X. Glnon and I. , Diagnostic de l'insuffisance cardiaque systolique, La Revue du Praticien, vol.52, p.1647, 2002.

M. A. Stevenson-l and Y. C. , Guideline update for the diagnosis and management of chronic heart failure in the adult, Journal American College of Cardiology, vol.46, pp.120-141, 2005.

Y. Jullllere, . N. Trochu-j, . De-groote-p, G. Hablb, . Hanon-o et al., M. lnsuffisance cardiaque à fonction systolique préservée: un algorithme diagnostique pour une définition pragmatique, Archives des Maladies du Coeur et des Vaisseaux, vol.99, issue.4, pp.4-7, 2006.

Y. Jullllere, lnsuffisance cardiaque : éducation thérapeutique : diététique. Malette 1-Care proposée pour l'éducation thérapeutique des patients insuffisants cardiaques adhérents a ICALOR

Y. S. Kober-l, . Pfeffer-m, M. G. Hall-a, . Torp-pedersen-c, . Ball-s et al., ACE-lnhibitor Myocardial lnfarction Collaborative Group Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systernatic overview of data from individual patients, Lancet, vol.355, pp.1575-1576, 2000.

C. The, Y. S. Trial-study-group, . Sleight-p, . Pogue-j, . Bosch-j et al., Effects of enalapril on mortality in severe congestive heart failure(23), pp 1429-1 435.Consulté juillet Effect of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, Results of the Cooperative North Scandinavian Enalapril Survival Study CONSENSUS. New England Journal of Medicine, vol.31, p.6, 1987.

S. The and . Investigators, Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

. Vo1, Consulté juillet, pp.293-302, 2007.

S. The, L. P. Investigators-ipsecsha, A. J. Belenkie-i, D. P. Demers-c, N. Glanettl et al., Consulté iuillet The 200213 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure, 10~685?iikev=339d2677b3082e0f00690750e9 166f2fd54292b4&kevtype2=tf, pp.685-691, 1992.

Y. Jullllere, Traitement médicamenteux de I'insuffisance cardiaque chronique, La Revue du Praticien, vol.52, pp.1672-1673, 2002.

Y. Jullllere, A. , A. Bolihour-j.-b, . A. Cohen-solal, . De-groote-p et al., Recommandations de la Société Européenne de Cardiologie et spécificités françaises concernant le diagnostic et le traitement de I'insuffisance cardiaque chronique, Archives des Maladies du Coeur et des Vaisseaux, vol.95, issue.2, 2002.

M. F. Study, P. M. Group, and C. R. Bristow-m, Consulté juillet 2007 à : http://www.ncbi.nlm.nih.qov/entrez/quew.fcqi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus &list uids=10376614&quew hl=9&itool=pubmed docsum for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, et al, for the US carvedilol Heart Failure Study group. Safety and efficacy of carvedilol in severe heart failure, 1999.

. Vo1, Consulté juillet, pp.173-174, 2007.

W. S. Coluccl, . Packer-m, and . R. Bristow-m, for the US carvedilol Heart Failure Study Group. Carvedilol inhibits clinical progression in patients with mild syrnptoms of heart failure, Circulation. Consulté juillet, vol.949411, pp.2800-2806, 1996.

K. H. , R. E. Mohacsi-p, R. J. Tendera-m, C. A. , and K. H. Fowler-m, 1765?maxtoshow=&HITS=l O&hits=l O&RE SULTFORMAT=&searchid=990803572289 21 753&stored search=&FIRSTINDEX=&volume= 90&firstpaqe=l765&search url=http%3A%2F%2Fcirc.ahaiournals.or~2Fcqi%2Fsearch&iour nalcode=circulationah ClBlS Investigators. The Cardiac lnsufficiency Bisoprolol Study II (CIBIS-II): a randomised trial pp 9-1 3. Consulté juillet 2007 à : http://www.ncbi.nlm.nih.qov/entrez/quew.fcqi?cmd=Retrieve&db=PubMed&list uids=l002394 3&dopt=Abstract DARGIE H Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, PACKER M. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study, pp.1765-1766, 1999.

P. P. Consulté-juillet-d, C. J. Swedberg-k, H. A. Di, L. J. Komajda-m, . Lutiger-b et al., Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Imperia1 College, 2003.

W. R. Van-veldhuisen-d, B. Sllke, F. F. Erdmann-e, K. H. Ponlkowskl, P. Skehle et al., Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) 111. Circulation, ClBlS III Investigators. Department of Cardiology, vol.11, pp.2-2426, 2005.

B. Pltt, R. Zannad-f, C. R. , C. A. Perez-a, P. J. et al., for The Randomized Aldactone Evaluation Study Investigators. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure, New England Journal of Medicine, vol.34110, issue.10, p.709, 1999.

S. , S. Yuslif, D. Phil-;-karl, and . Swedberg, Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low-Left Ventricular Ejection Fraction Trials, Circulation

B. Pltt, . Segal-r, . A. Martinez-f, C. A. Melirers-g, T. I. Deedwania-p et al., Randornised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE), I. Division of Cardiology Lancet, vol.349, issue.9054, pp.747-752, 1997.

K. M. , R. G. Klinger-g, N. J. Sharma-d, and . Thiyagarajan-b, Division of Cardiology, University of Michigan School of Medicine, Ann Arbor 48109-0366, USA. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study: ELITE II, Journal of Cardiac Failure, vol.5, issue.2, pp.146-147, 1999.

M. R. and Y. S. Pericak-d, Comparison of candesartan, enalapril and their combination in congestive heart failure Randomized Evaluation of Strategies for Left-Ventricular Dysfunction (RESOL VD) Pilot study. Circulation Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure, Consulté juillet, vol.102, issue.34523, pp.1056-1057, 1999.

M. Hearf, M. J. Ostergren, . Swedberg-k, . B. Granger-c, . Held-p et al., Hôpital Pitié-Salpétriere, Paris. Consulté octobre Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial, A. CHARM Investigators and Comrnittees Lancet, vol.87, issue.3629386, pp.767-771, 2003.

K. Dlcksteln, K. J. Steering-committee, P. M. Mcmurray-j, A. Lelzorovlcz, A. P. Magglonl et al., Effects of losartan and captopril on mortality and rnorbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomized trial Consulté octobre, Valsartan in Acute Myocardial lnfarction Trial (VALIANT), pp.752-760, 2002.

M. Consulté-octobre-l, C. M. Packer, J. K. O-'connor, M. L. Ghali, P. E. Pressler et al., For The Prospective Randomized Arnlodipine Survival Evaluation Study Group. Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure, Consulté octobre, 1107.

Y. I. , A. W. Smith-al, L. A. , L. R. Wilkoff-b, C. R. et al., Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial, JAMA. Consulté juillet, vol.289, issue.20, pp.2685-2694, 2003.

C. P. Dicarlo-l, D. D. White-bg, D. D. , and F. A. , Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, New England Journal of Medicine, vol.350, issue.21, pp.40-61, 2004.

A. M. , A. J. Cohen-solal, D. J. De-groote-p, . Delahaye-f, D. E. Desnos-m et al., Insuffisance cardiaque et cardiomyopathies, Archives des Maladies du Coeur et des Vaisseaux, vol.02, pp.9-23, 2006.

K. , D. M. Mancini, M. Kelth, J. A. Oates, P. S. Rahko et al., American College of Cardiology Foundation. Diagnosis and Management of Chronic Heart Failure in the Adult

S. A. , A. W. Chln, M. H. Feldman-a, F. G. Ganiats-t, K. M. Jessup-m et al., Guideline update for the diagnosis and management of chronic heart failure in the adult, Journal American College of Cardiology, vol.46, issue.1, p.121, 2005.

D. A. , A. I. , M. F. Ottenheim-c, and . Sandrin-berthon-b, Séminaire d'été d'éducation pour la santé) Comité français d'éducation pour la santé. L'éducation pour la santé en médecine générale. De la fonction curative à la fonction éducative, p.53, 1996.

D. J. Une, . <<-relecture, and . Ottawa, Santé publique, pp.3-325, 2003.

C. M. Schoonbroodt-c, Guide pratique d'éducation pour la santé: réflexion, expérimentation et 50 fiches à l'usage des formateurs. Bruxelles, pp.179-180, 1992.